MedPath

Comparative Study Between Ormeloxifene And Norethisterone In The Management Of Patients Having Dysfunctional Uterine Bleeding : Prospective Randomized Study

Phase 4
Conditions
Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle
Registration Number
CTRI/2019/08/020648
Lead Sponsor
Shri Sathya Sai Medical College And Research Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Women aged between 19-45 years with diagnosis of AUB

Exclusion Criteria

Hypersensitivity to the drug

Medical disorders

Women desirous of fertility

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study effect of ormeloxifene on endometrial thickness in comparision with norethisteroneTimepoint: 12weeks
Secondary Outcome Measures
NameTimeMethod
Reduction in menstrual blood lossTimepoint: 12 weeks
© Copyright 2025. All Rights Reserved by MedPath